AB Science S.A. (ABSCF)

2.7000 0.0000 (0.00%) At close: 09:47AM EDT

AB Science S.A.

3, avenue George V
Paris 75008
France
33 1 47 20 00 14
https://www.ab-science.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 89

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Alain Moussy MBA	Co-Founder, Chairman, President, CEO, MD & Scientific Director	635.86k	N/A	N/A
Mr. Laurent Guy MBA	Chief Financial Officer	N/A	N/A	N/A
Mr. Christian FASSOTTE	Global Chief Medical Officer	N/A	N/A	N/A
Mr. Alexis BERNARD	Head of Veterinary Sales	N/A	N/A	N/A
Mr. Harshad KULKARNI	Head of Statistics	N/A	N/A	N/A
Dr. Albert Ahn D.V.M.	President of USA Operations	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company is also developing AB8939, a synthetic microtubule destabiliser for haematology indications. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.

Corporate Governance

AB Science S.A.’s ISS Governance QualityScore as of April 1, 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.